Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1969 2
1970 4
1971 2
1972 5
1974 1
1975 2
1976 2
1978 2
1979 1
1980 1
1983 2
1984 3
1985 2
1986 9
1987 6
1988 2
1989 2
1990 5
1991 7
1992 1
1993 4
1994 5
1995 3
1996 5
1997 8
1998 4
1999 4
2000 2
2001 1
2002 4
2003 11
2004 6
2005 17
2006 8
2007 7
2008 10
2009 12
2010 14
2011 20
2012 14
2013 14
2014 18
2015 15
2016 15
2017 20
2018 18
2019 22
2020 23
2021 15
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

351 results
Results by year
Filters applied: . Clear all
Page 1
Towards personalized treatment for early stage HER2-positive breast cancer.
Goutsouliak K, Veeraraghavan J, Sethunath V, De Angelis C, Osborne CK, Rimawi MF, Schiff R. Goutsouliak K, et al. Among authors: schiff r. Nat Rev Clin Oncol. 2020 Apr;17(4):233-250. doi: 10.1038/s41571-019-0299-9. Epub 2019 Dec 13. Nat Rev Clin Oncol. 2020. PMID: 31836877 Free PMC article. Review.
The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells.
Bado IL, Zhang W, Hu J, Xu Z, Wang H, Sarkar P, Li L, Wan YW, Liu J, Wu W, Lo HC, Kim IS, Singh S, Janghorban M, Muscarella AM, Goldstein A, Singh P, Jeong HH, Liu C, Schiff R, Huang S, Ellis MJ, Gaber MW, Gugala Z, Liu Z, Zhang XH. Bado IL, et al. Among authors: schiff r. Dev Cell. 2021 Apr 19;56(8):1100-1117.e9. doi: 10.1016/j.devcel.2021.03.008. Dev Cell. 2021. PMID: 33878299 Free PMC article.
Mechanisms of endocrine resistance in breast cancer.
Osborne CK, Schiff R. Osborne CK, et al. Among authors: schiff r. Annu Rev Med. 2011;62:233-47. doi: 10.1146/annurev-med-070909-182917. Annu Rev Med. 2011. PMID: 20887199 Free PMC article. Review.
Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? : A Randomized Trial.
Shepperd S, Butler C, Cradduck-Bamford A, Ellis G, Gray A, Hemsley A, Khanna P, Langhorne P, Mort S, Ramsay S, Schiff R, Stott DJ, Wilkinson A, Yu LM, Young J. Shepperd S, et al. Among authors: schiff r. Ann Intern Med. 2021 Jul;174(7):889-898. doi: 10.7326/M20-5688. Epub 2021 Apr 20. Ann Intern Med. 2021. PMID: 33872045 Free PMC article. Clinical Trial.
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.
Schettini F, Pascual T, Conte B, Chic N, Brasó-Maristany F, Galván P, Martínez O, Adamo B, Vidal M, Muñoz M, Fernández-Martinez A, Rognoni C, Griguolo G, Guarneri V, Conte PF, Locci M, Brase JC, Gonzalez-Farre B, Villagrasa P, De Placido S, Schiff R, Veeraraghavan J, Rimawi MF, Osborne CK, Pernas S, Perou CM, Carey LA, Prat A. Schettini F, et al. Among authors: schiff r. Cancer Treat Rev. 2020 Mar;84:101965. doi: 10.1016/j.ctrv.2020.101965. Epub 2020 Jan 17. Cancer Treat Rev. 2020. PMID: 32000054 Free PMC article.
Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.
Bi M, Zhang Z, Jiang YZ, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang TH, Shao ZM, Schiff R, Chen L, Liu Z. Bi M, et al. Among authors: schiff r. Nat Cell Biol. 2020 Jun;22(6):701-715. doi: 10.1038/s41556-020-0514-z. Epub 2020 May 18. Nat Cell Biol. 2020. PMID: 32424275 Free PMC article.
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.
Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ. Meerbrey KL, et al. Among authors: schiff r. Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9. Proc Natl Acad Sci U S A. 2011. PMID: 21307310 Free PMC article.
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.
Terunuma A, Putluri N, Mishra P, Mathé EA, Dorsey TH, Yi M, Wallace TA, Issaq HJ, Zhou M, Killian JK, Stevenson HS, Karoly ED, Chan K, Samanta S, Prieto D, Hsu TY, Kurley SJ, Putluri V, Sonavane R, Edelman DC, Wulff J, Starks AM, Yang Y, Kittles RA, Yfantis HG, Lee DH, Ioffe OB, Schiff R, Stephens RM, Meltzer PS, Veenstra TD, Westbrook TF, Sreekumar A, Ambs S. Terunuma A, et al. Among authors: schiff r. J Clin Invest. 2014 Jan;124(1):398-412. doi: 10.1172/JCI71180. Epub 2013 Dec 9. J Clin Invest. 2014. PMID: 24316975 Free PMC article.
351 results